Posted by Admin
Post Date : Friday June 29 2007

FA was diagnosed with stage 4, non small cell lung (NSCLC) cancer at age 61. She was given taxol and carboplatin, from July 2004 until the end of September 2004. According to a CT scan, the tumors size decreased by 50%. During this time she suffered two heart attacks, one that was silent after being given a flu shot on October 1. She underwent a catheterization and 2 complete blockages were found. The chemotherapy and the heart attack destroyed part of her heart muscle. She was put on medications and bypass surgery was not recommended because of her history of cancer. Since her heart was affected by the chemotherapy she could no longer tolerate any chemotherapeutic drugs. Her lung cancer seemed to be stable and her oncologist wanted to switch her to Iressa. However she couldn’t afford it and her insurance refused to cover this very expensive drug. She went to see an integrative physician who told her about Poly-MVA. In October she started taking Poly-MVA and quickly worked up her dose to 8 teaspoons per day. Five months later her CT scan of her chest revealed no tumors. There was no longer evidence of lung cancer. Her heart condition was also stable. In December she decreased her dose of Poly-MVA to 1 teaspoon per day. She also takes 100 mg of CoQ10 and 4 capsules of fish oil each day. She has regular checkups with her oncologist as well as regular CT scans. If there is any recurrence she will immediately increase her dose of Poly-MVA to 8 teaspoons per day. Her oncologist told her after her remission that only 10% of the people diagnosed with NSCLC are cured (generally not stage 4) and that in general it can only be controlled. FA was told by the oncologist that she had at most one year even with aggressive treatment. Iressa was taken off the market. The oncologist told the patient, “what ever you are doing – keep doing it.” In June 2007, FA’s oncologist received laboratory results and told patient she is doing great and remains in remission.

6/22/07 - Received laboratory analysis and notes from oncologist stating that patient is doing great. She remains on the same protocol. Her new data is dated 5/23/07.

1/22/08 - A comparison x-ray was performed on 12/19/08 by her oncologist and compared to her x-ray on 10/07/05. The report is as follows: “The cardiac silhouette is not enlarged. The pulmonary vasculature is within normal. No acute lobar infiltrate or pleural effusion is seen. Left central venous catheter is unchanged in appearance. No pneumothorax. Mild degenerative changes thoracic spine. Degenerative changes both shoulders. Impression: no radiographic evidence for acute chest process.” FA remains in full clinical remission.

4/21/08 - Two views of chest, PA and lateral. PA and lateral views of chest show the lungs are clear. Her oncologist asked her if she is still on her natural product. She told him yes and he is now very interested in it. He will be contacting Dr. Paul Rothwell to discuss.

Case study written by Dr. Shari Lieberman as a part of the Poly-MVA Best Case Series.